Skip to main content

Table 1 Baseline patient characteristics

From: Morbidity associated with systemic corticosteroid preparation for coronary artery bypass grafting in patients with chronic obstructive pulmonary disease: a case control study

  Diprospan group
(n = 30)
Placebo group
(n = 30)
Control group
(n = 30)
P value*
Male/Female, n 26/4 24/6 27/3 NS
Age, yr (mean ± SD) 67.0 ± 8.98 67.7 ± 9.2 66.4 ± 9.9 NS
Smokers/nonsmokers, n 24/6 26/4 20/10 NS
FEV1,, %
(mean ± SD)
60.6 ± 9.5 62.6 ± 8.0 88.6 ± 7.1 0.001
LVEF, %
(mean ± SD)
46.1 ± 12.4 46.1 ± 11.8 47.8 ± 10.3 NS
ASA class, n     
2 0 0 2  
3 16 21 23  
4 14 9 5 0.04
  1. *Between COPD groups (treatment+placebo) and controls.